• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Glyscend Doses First GLY-200 Obesity Phase 2 Patient

    BUSINESSWIRE

    Glyscend Appoints Sapan A. Shah Accomplished Industry Executive, as CEO

    BUSINESSWIRE

    Glyscend Therapeutics` early data show polymer mimics benefits

    ENDPTS

    Glyscend Announces Positive Topline Phase 2a Clinical Results of GLY-200

    BUSINESSWIRE

    Glyscend Appoints Biotech Industry Veteran Michael Wyzga to Board of Directors

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.